EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE IS A HISTAMINE OR HISTAMINE-LIKE RECEPTOR
EVIDENCE THAT THE ANTIESTROGEN BINDING-SITE IS A HISTAMINE OR HISTAMINE-LIKE RECEPTOR
复制标题
DOI:
10.1016/0006-291x(85)90271-2
复制
发表时间:
1985-01-01
影响因子:
3.1
通讯作者:
MACDONALD, LM
中科院分区:
文献类型:
--
作者:
BRANDES, LJ;MACDONALD, LM
N,N-diethyl-2-[(4-phenylmethyl)-phenoxy]-ethanamine.cntdot.HCl(DPPE), a compound selective for the antiestrogen binding site, is structurally similar to the aminoethyl ether group of antihistamines. H1-, but not H2-antagonists, apparently, also compete for this site in the order; DPPE = hydroxyzine = perchlorperazine > phenyltoloxamine > pyrilamine > diphenhydramine. The affinity of these compounds for the antiestrogen binding site correlates with their in vitro cytotoxicity against MCF-7 and EVSA-T human breast cancer cells. Tamoxifen, DPPE and hydroxyzine also bind to H1 receptors present in digitonin-solubilized rat liver microsomes, but with less affinity than pyrilamine, which is selective for this site; the ratio of H1 to antiestrogen binding sites in this preparation is 4:1. The antiestrogen binding site may be, in whole or in part, a receptor for histamine different from H1 and H2.